Triumph-NK develops a vaccine against respiratory viruses
The Triumph-NK project is developing a vaccine that programs lung cells to recognize and fight a wide range of respiratory viruses based on past exposure.
- Field
- medicine and diagnostics
- What they did
- Researchers at the University of Southampton are developing a new type of vaccine that can teach lung cells how to remember ways to fight viruses.
- Why it matters
- This vaccine could protect against a wide range of respiratory viruses, including influenza and RSV, and be ready for immediate use during an outbreak or even a pandemic.
#vaccine#lung cells#triumph-nk#respiratory viruses#immunology



